Literature DB >> 6367664

Linear IgA bullous dermatosis v dermatitis herpetiformis. Quantitative measurements of dermoepidermal alterations.

S B Smith, T J Harrist, G F Murphy, A J Halperin, J B Newell, J T Fallon, J D Fine, M C Mihm.   

Abstract

Linear IgA bullous dermatosis (LAD), also known as "atypical dermatitis herpetiformis," is a disorder that is distinct from classic dermatitis herpetiformis (DH). In eight patients with DH and six with LAD, quantitative assessment of a variety of histopathologic variables was made. The number of rete tips with neutrophils in basal vacuoles and the length of the epidermal basement membrane zone (BMZ) associated with these findings were greater in LAD than DH. The number of microabscesses of neutrophils in the dermal papillae and the length of epidermal BMZ associated with them were greater in DH than in LAD. By using the number of microabscesses and the number of rete tips with neutrophils in basal vacuoles in a probability model, we found by retrospective analysis that a correct diagnosis could be made for LAD in 75% of biopsy specimens with a probability of 97% and in all cases of DH with a probability of 92%. Using this model, we made no misdiagnoses. This is the first diagnostic probability model in dermatopathology that expresses a confidence level in diagnosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6367664

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  2 in total

1.  Bullous Dermatosis in an End-Stage Renal Disease Patient: A Case Report and Literature Review.

Authors:  Zeenat Yousuf Bhat; Marwan Abu Minshar; Nashat Imran; Andrew Thompson; Yahya Osman Malik
Journal:  Case Rep Nephrol       Date:  2016-11-24

2.  Histologic characterization of cellular infiltration in autoimmune subepidermal bullous diseases in a tertiary hospital in Saudi Arabia.

Authors:  Hessah F BinJadeed; Alanoud M Alyousef; Fahad M Alsaif; Ahmed A Alhumidi; Homaid O Alotaibi
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-04-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.